| Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ... American Journal of Psychiatry 174 (3), 216-229, 2017 | 1002 | 2017 |
| Gut microbiota and major depressive disorder: a systematic review and meta-analysis K Sanada, S Nakajima, S Kurokawa, A Barceló-Soler, D Ikuse, A Hirata, ... Journal of affective disorders 266, 1-13, 2020 | 308 | 2020 |
| Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies S Moriguchi, A Takamiya, Y Noda, N Horita, M Wada, S Tsugawa, ... Molecular psychiatry 24 (7), 952-964, 2019 | 270 | 2019 |
| Kynurenine pathway in depression: A systematic review and meta-analysis K Ogyu, K Kubo, Y Noda, Y Iwata, S Tsugawa, Y Omura, M Wada, ... Neuroscience & Biobehavioral Reviews 90, 16-25, 2018 | 259 | 2018 |
| Kynurenic acid in schizophrenia: a systematic review and meta-analysis E Plitman, Y Iwata, F Caravaggio, S Nakajima, JK Chung, P Gerretsen, ... Schizophrenia bulletin 43 (4), 764-777, 2017 | 225 | 2017 |
| The potential role of dopamine D3 receptor neurotransmission in cognition S Nakajima, P Gerretsen, H Takeuchi, F Caravaggio, T Chow, B Le Foll, ... European Neuropsychopharmacology 23 (8), 799-813, 2013 | 214 | 2013 |
| Glutamate-mediated excitotoxicity in schizophrenia: a review E Plitman, S Nakajima, C de la Fuente-Sandoval, P Gerretsen, ... European Neuropsychopharmacology 24 (10), 1591-1605, 2014 | 182 | 2014 |
| Glutamatergic neurometabolite levels in patients with ultra-treatment-resistant schizophrenia: a cross-sectional 3T proton magnetic resonance spectroscopy study Y Iwata, S Nakajima, E Plitman, F Caravaggio, J Kim, P Shah, W Mar, ... Biological psychiatry 85 (7), 596-605, 2019 | 119 | 2019 |
| Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials Y Iwata, S Nakajima, T Suzuki, RSE Keefe, E Plitman, JK Chung, ... Molecular psychiatry 20 (10), 1151-1160, 2015 | 112 | 2015 |
| Insight and medication adherence in schizophrenia: an analysis of the CATIE trial J Kim, M Ozzoude, S Nakajima, P Shah, F Caravaggio, Y Iwata, ... Neuropharmacology 168, 107634, 2020 | 107 | 2020 |
| Neuroimaging findings in treatment-resistant schizophrenia: a systematic review: lack of neuroimaging correlates of treatment-resistant schizophrenia S Nakajima, H Takeuchi, E Plitman, G Fervaha, P Gerretsen, ... Schizophrenia research 164 (1-3), 164-175, 2015 | 106 | 2015 |
| Accelerating response to antidepressant treatment in depression: a review and clinical suggestions S Nakajima, T Suzuki, K Watanabe, H Kashima, H Uchida Progress in Neuro-Psychopharmacology and Biological Psychiatry 34 (2), 259-264, 2010 | 103 | 2010 |
| Psychosis in frontotemporal dementia S Shinagawa, S Nakajima, E Plitman, A Graff-Guerrero, M Mimura, ... Journal of Alzheimer's disease 42 (2), 485-499, 2014 | 100 | 2014 |
| Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies T Nakahara, S Tsugawa, Y Noda, F Ueno, S Honda, M Kinjo, H Segawa, ... Molecular psychiatry 27 (1), 744-757, 2022 | 95 | 2022 |
| Effectiveness of the prefrontal repetitive transcranial magnetic stimulation on cognitive profiles in depression, schizophrenia, and Alzheimer's disease: a systematic review T Iimori, S Nakajima, T Miyazaki, R Tarumi, K Ogyu, M Wada, S Tsugawa, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 88, 31-40, 2019 | 90 | 2019 |
| Evaluation of antipsychotic dose reduction in late-life schizophrenia: a prospective dopamine D2/3 receptor occupancy study A Graff-Guerrero, TK Rajji, BH Mulsant, S Nakajima, F Caravaggio, ... JAMA psychiatry 72 (9), 927-934, 2015 | 88 | 2015 |
| The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: a systematic review P Shah, Y Iwata, E Plitman, EE Brown, F Caravaggio, J Kim, S Nakajima, ... Psychiatry research 268, 114-122, 2018 | 87 | 2018 |
| Dental conditions in inpatients with schizophrenia: A large-scale multi-site survey H Tani, H Uchida, T Suzuki, Y Shibuya, H Shimanuki, K Watanabe, R Den, ... BMC Oral Health 12, 1-6, 2012 | 81 | 2012 |
| Reduced Insulin Sensitivity Is Related to Less Endogenous Dopamine at D2/3 Receptors in the Ventral Striatum of Healthy Nonobese Humans F Caravaggio, C Borlido, M Hahn, Z Feng, G Fervaha, P Gerretsen, ... International Journal of Neuropsychopharmacology 18 (7), pyv014, 2015 | 80 | 2015 |
| The evolution of antipsychotic switch and polypharmacy in natural practice—a longitudinal perspective C Tsutsumi, H Uchida, T Suzuki, K Watanabe, H Takeuchi, S Nakajima, ... Schizophrenia research 130 (1-3), 40-46, 2011 | 79 | 2011 |
